LegalizeThe Cosmetic Products (Safety) Regulations 1989
Made: 29th November 1989
Laid before Parliament: 6th December 1989
Coming into force
Now, therefore, the Secretary of State in exercise of powers conferred on him by sections 11, 28 and 30 of the said Act of 1987 and by section 2 of the said Act of 1972 and of all other powers enabling him in that behalf hereby makes the following Regulations:–
Citation, commencement and revocation
1
- (1) These Regulations may be cited as the Cosmetic Products (Safety) Regulations 1989 and except as provided by paragraphs (2) to (5) below shall come into force on 1st January 1990.
- (2) Regulation 4(2) and Schedule 1, in so far as they relate only to entry numbers 37, 38, 47 (cross-referenced in column 3 with entry number 496) and 87 and to entry numbers 247, 558 and 680 (cross-referenced in column 3 with entry numbers 351, 454 and 132 respectively) in that Schedule, regulation 4(3) and Part I of Schedule 2, in so far as they relate only to entry number 52 in that Part, and regulation 4(5) and Part I of Schedule 4, in so far as they relate only to entry number 40 and the deletion of entry number 6 in that Part, shall come into force–
- (a) on 1st January 1990 in relation to the supply of cosmetic products by the manufacturer in or importer into the United Kingdom or, in the case of cosmetic products manufactured or imported into the United Kingdom on behalf of another person, by that other person, except where the cosmetic products are supplied by retail in which case they shall come into force on 1st January 1991; and
- (b) in all other cases, on 1st January 1991.
- (3) Regulation 4(3) and Schedule 2, in so far as they relate only to entry numbers 53 and 54 in Part 1 of Schedule 2, regulation 4(4)(a)(i) and Part I of Schedule 3, in so far as they relate to the deletion of colouring agent 13065, and regulation 4(5) and Part II of Schedule 4, in so far as they relate to the deletion of entry numbers 7 to 10, 14, 18, 22 and 24 in that Part, shall come into force–
- (a) on 1st January 1990 in relation to the supply of cosmetic products by the manufacturer in or importer into the United Kingdom or, in the case of cosmetic products manufactured or imported into the United Kingdom on behalf of another person, by that other person, except where the cosmetic products are supplied by retail in which case they shall come into force on 1st January 1992; and
- (b) in all other cases, on 1st January 1992.
- (4) Regulation 4(3) and Part II of Schedule 2, in so far as they relate only to entry number 1 in that Part, regulation 4(4) and Part II of Schedule 3, in so far as they relate only to the deletion of entry numbers 15800, 19120, 20470, 21115, 42170, 45190, 47000, 73905 and 75660 and the requirement in column 4 relating to entry number 42535 in that Part, regulation 4(5) and Part I of Schedule 4, in so far as they relate only to the requirement in column 4 relating to entry number 39 in that Part, and Part II of Schedule 4, in so far as they relate only to entry number 26 and the deletion of entry numbers 1, 3, 5, 19 and 25 in that Part, and regulation 4(6)(a)(ii) and Part II of Schedule 5 shall come into force–
- (a) on 1st January 1991 in relation to the supply of cosmetic products by the manufacturer in or importer into the United Kingdom or, in the case of cosmetic products manufactured or imported into the United Kingdom on behalf of another person, by that other person, except where the cosmetic products are supplied by retail in which case they shall come into force on 1st January 1993; and
- (b) in all other cases, on 1st January 1993.
- (5) Regulation 6 shall come into force–
- (a) on 1st January 1992 in relation to the supply of cosmetic products by the manufacturer in or importer into the United Kingdom or, in the case of cosmetic products manufactured or imported into the United Kingdom on behalf of another person, by that other person, except where the cosmetic products are supplied by retail in which case it shall come into force on 1st January 1994; and
- (b) in all other cases on 1st January 1994.
- (6) Subject to paragraph (7) below, the Regulations specified in Schedule 7 are hereby revoked:
- (7) The notes in Schedules 3 and 4 shall apply.
Interpretation
2
- (1) In these Regulations–
- “the Directive” means Council Directive No. 76/768/EEC[^f00004] as amended by Council Directive No. 82/368/EEC[^f00005], Commission Directive No. 82/147/EEC[^f00006], Commission Directive No. 83/191/EEC[^f00007], Commission Directive No. 83/341/EEC[^f00008], Council Directive No. 83/574/EEC[^f00009], Commission Directive No. 83/496/EEC[^f00010], Commission Directive No. 84/415/EEC[^f00011], Commission Directive No. 85/391/EEC[^f00012], Commission Directive No. 86/179/EEC[^f00013], Commission Directive No. 86/199/EEC[^f00014], Commission Directive No. 87/137/EEC[^f00015], Commission Directive No. 88/233/EEC[^f00016], Council Directive No. 88/667/EEC[^f00017] and Commission Directive No. 89/174/EEC[^f00018];
- “cosmetic product” means any substance or preparation intended to be applied to any part of the external surfaces of the human body (that is to say, the epidermis, hair system, nails, lips and external genital organs) or to the teeth or buccal mucosa wholly or mainly for the purpose of cleaning, perfuming or protecting them or keeping them in good condition or changing their appearance or combating body odour or perspiration except where such cleaning, perfuming, protecting, keeping, changing or combating is wholly for the purpose of treating or preventing disease;
- “cosmetic product intended to come into contact with the mucous membranes” means a cosmetic product intended to be applied in the vicinity of the eyes, on the lips, in the oral cavity or to the external genital organs, and does not include any cosmetic product which is intended to come into only brief contact with the skin;
- “market research experiment” means any activities conducted for the purpose of ascertaining the opinion of persons of– any cosmetic product; or anything in, on or with which the cosmetic product is supplied; or the appearance or any other characteristic of the cosmetic product or any such thing; or the name or description under which the cosmetic product is supplied.
- A cosmetic product is not the subject of a market research experiment unless– any person to whom a cosmetic product is supplied in the course of the experiment is informed, at or before the time at which it is supplied to him, that it is supplied for the purpose of a market research experiment and no consideration in money or money’s worth is given by such a person for the cosmetic product or any other cosmetic product supplied to him for comparison.
- “preservative” means a substance which is added to a cosmetic product for the primary purpose of inhibiting the development of micro-organisms in that product;
- “supply” includes offering to supply, agreeing to supply, exposing for supply and possessing for supply, and cognate expressions shall be construed accordingly; and
- “UV filter” means a substance which is added to a sunscreen cosmetic product for the primary purpose of filtering ultra violet rays for the purpose of protecting the epidermis of the user from harmful effects of such ultra violet rays.
- (2) References in these Regulations to a numbered regulation or Schedule are references to the regulation or Schedule so numbered in these Regulations.
General Requirements
3
- (1) Subject to paragraph (2) below, a cosmetic product shall not be liable to cause damage to human health when it is applied under normal conditions of use.
- (2) For the purposes of regulation 8, paragraph (1) above shall apply only to the supply by the manufacturer in or importer into the United Kingdom or, in the case of cosmetic products manufactured or imported into the United Kingdom on behalf of another person, by that other person.
Particular requirements
4
- (1) The following provisions of this regulation are without prejudice to regulation 3 and are subject to regulation 5.
- (2) A cosmetic product shall not contain any substance listed in column 2 of Schedule 1:
Provided that no account shall be taken of any such substance which is present only as a trace which could not reasonably have been removed during or after manufacture.
- (3) A cosmetic product shall not contain any substance listed in column 2 of Schedule 2 unless the requirements in columns 3, 4, 5 and (in the case of Part II) 7 of that Schedule in relation to that substance are satisfied.
- (4) A cosmetic product shall not contain–
- (a) any colouring agent listed in columns 1 and 2 of Schedule 3 with the exception of cosmetic products containing colouring agents intended solely to colour hair unless–
- (i) the requirements in columns 3 and 4 of Part I of that Schedule in relation to that colouring agent are satisfied; or
- (ii) the requirements in columns 3 and 4 of Part II of that Schedule in relation to that colouring agent are satisfied and the cosmetic product in question was supplied on or before the date specified in column 5 of that Part;
- (b) any colouring agent which is not listed in that Schedule with the exception of cosmetic products containing colouring agents intended solely to colour hair;
- (5) A cosmetic product shall not contain–
- (a) any preservative listed in column 2 of Schedule 4 unless–
- (i) the requirements in columns 3, 4 and 5 of Part I of that Schedule in relation to that preservative are satisfied; or
- (ii) the requirements in columns 3, 4 and 5 of Part II of that Schedule in relation to that preservative are satisfied and the preservative in question is supplied on or before the date specified in column 7 of that Part;
- (b) any preservative which is not listed in that Schedule;
- (c) any preservative listed in column 2 of Part II of Schedule 4 after the date specified in column 7 of that Part.
- (6) A cosmetic product shall not contain–
- (a) any UV filter listed in column 2 of Schedule 5 unless–
- (i) the requirements in columns 3 and 4 of Part I of that Schedule in relation to that UV filter are satisfied; or
- (ii) the requirements in columns 3 and 4 of Part II of that Schedule in relation to that UV filter are satisfied and the UV filter in question is supplied on or before the date specified in column 6 of that Part;
- (b) any UV filter which is not listed in that Schedule.
5
- (1) The Secretary of State may authorise the use in a cosmetic product of a particular substance, not being a substance listed in Schedule 1 or 2.
- (2) In giving an authorisation the Secretary of State may impose conditions relating to the use of a particular substance in a cosmetic product. The conditions may relate to any matter which the Secretary of State considers appropriate including–
- (a) the purpose of the substance;
- (b) the type of cosmetic product;
- (c) the maximum concentration of the substance in any cosmetic product; and
- (d) information and marking requirements.
- (3) The Secretary of State may on reasonable notice vary or revoke any authorisation given under paragraph (1) above.
- (4) On giving, varying or revoking an authorisation, the Secretary of State shall arrange for the authorisation, variation or revocation, as the case may be, to be published in such manner as he considers appropriate for bringing it to the attention of persons who, in his opinion, would be likely to have an interest in it.
- (5) No person shall be convicted of an offence under section 12 of the Consumer Protection Act 1987 by reason of a cosmetic product’s containing a particular substance provided that at the time when but for this regulation an offence would have been committed–
- (a) the use of that particular substance in that cosmetic product was duly authorised; and
- (b) all of the conditions imposed by the authorisation were complied with.
Marking
6
- (1) Subject to the following provisions of this regulation, the container and the outer packaging (if any) in which a cosmetic product is supplied or delivered pursuant to any supply, or a label affixed to the product, the container and the outer packaging, shall bear the following particulars:–
- (a) the name or trade name and the address or registered office of the manufacturer of the product or of a supplier thereof, being a manufacturer or supplier established within a member State of the European Economic Community;
- (b) in the case of a cosmetic product likely within 30 months from the manufacture thereof to cease either to comply with the requirements of regulation 3 or to fulfil the purpose for which it was intended, the words “Best before ” immediately followed by
- (i) the earliest date on which it is likely to so cease; or
- (ii) an indication of where that date appears on the labelling
and any particular precautions to be observed to ensure that the product does not so cease before that date.
- (c) in the case of a cosmetic product containing a substance listed in column 2 of Schedule 2, the information specified in column 6 of that Schedule in relation to that substance;
- (d) in the case of a cosmetic product containing a preservative listed in column 2 of Schedule 4, the information specified in column 6 of that Schedule in relation to that preservative;
- (e) in the case of a cosmetic product containing a UV filter listed in column 2 of Schedule 5, the information specified in column 5 of that Schedule in relation to that UV filter;
- (f) any particular precautions to be observed in use (not being precautions included in the information referred to in sub-paragraphs (b), (c), (d) and (e) above);
- (g) a means of identifying the batch in which the product was manufactured (or, if the product was not manufactured in a batch, a reference from which the date and place of manufacture can be identified):
Provided that the requirements specified in sub-paragraphs (b) and (g) above need not be complied with in relation to a cosmetic product which is the subject of a market research experiment.
- (2) The particulars referred to in sub-paragraphs (a) to (g) of paragraph (1) above shall be in lettering which is visible, indelible and easily legible.
- (3) The particulars referred to in sub-paragraph (a) of paragraph (1) above may be abbreviated if such abbreviation does not prevent the person concerned from being identified.
- (4) The date referred to in sub-paragraph (b) of paragraph (1) above shall include the month and the year, and the month shall precede the year.
- (5) The particulars referred to in sub-paragraphs (b) to (f ) of paragraph (1) above shall be in the English language; but this shall not prohibit the additional use of other languages.
- (6) The particulars referred to in sub-paragraphs (c) to (f ) of paragraph (1) above and any special precautionary information on cosmetic products for professional use, in particular, in hairdressing shall appear on the container or on a label attached thereto: provided that where–
- (a) it is impracticable by reason of the size or shape of the container for the said particulars so to appear, or
- (b) two or more products are supplied together as a single item, each product being in a separate container and the containers being enclosed together in outer packaging which bears clear and conspicuous instructions to the effect that the product must be mixed together in specified proportions before use,
the said particulars shall appear on an enclosed leaflet and an indication shall appear on both the container and the outer packaging (if any) or on a label if attached thereto referring the consumer to the information in the leaflet.
- (7) Where it is impracticable, for reasons of size, for the particulars referred to in sub-paragraph (g) of paragraph (1) above to appear on the container and outer packaging, the said particulars shall appear on the packaging in which the product is exposed for supply.
- (8) In the case of a supply of soap which is not in a container, either the soap itself or the packaging in which it is exposed for supply or the container in which it was last contained before the supply shall bear the particulars referred to in sub-paragraphs (a) and (g) of paragraph (1) above, and in so far as any of the particulars referred to in sub-paragraphs (b) to (f) of paragraph (1) above are required they shall appear on a leaflet which shall be delivered to the buyer with the soap; and where either of the particulars referred to in sub-paragraphs (a) and (g) of paragraph (1) above appears on the soap itself the requirement of indelibility shall apply only until it has been put into use.
Enforcement
7
- (1) No proceedings for an offence under section 12 of the Consumer Protection Act 1987 in respect of a contravention of regulation 8 by reason of the requirements of regulation 3 being not satisfied shall be brought in England or Wales except by or with the consent of the Secretary of State or the Director of Public Prosecutions and in Northern Ireland except by or with the consent of the Secretary of State or the Director of Public Prosecutions for Northern Ireland.
- (2) Regulations 3, 4 and 6 do not apply in any case in which the cosmetic product is supplied for the purposes of exporting that product to any country which is not a member State of the European Economic Community.
- (3) Regulation 6(5) does not apply in any case in which the person supplying the cosmetic product reasonably believes that it will not be used in the United Kingdom.
8
Subject to regulations 5 and 7(2) and (3), no person shall supply any cosmetic product in respect of which any of the requirements of regulation 3, 4 or 6 is not satisfied.
9
Any test of goods purchased under section 28, or seized under section 29, of the Consumer Protection Act 1987 (which relates to enforcement) by or on behalf of an enforcement authority for the purpose of ascertaining whether the provisions of these Regulations have been contravened shall in all cases be carried out in accordance with the provisions of paragraphs 2 to 5 of Schedule 6 and any test for which a method is specified in paragraph 6 of that Schedule shall be carried out in accordance with that method.
SCHEDULE 1 — LIST OF SUBSTANCES WHICH COSMETIC PRODUCTS MUST NOT CONTAIN
The alphabetical list set out in column 2 of this Schedule contains one or more of the names of each of the substances referred to in regulation 4(2); in certain cases a name is given of a group of substances, the names of particular examples of which are also given, and in such a case all substances comprised in the group are included, whether or not more specifically named.
The numbers given in columns 1, 3 and 4 are for information only. Those in column 3 are cross-references to other names listed for the same substances (except that where a name is that of a group of substances, the cross-references are to particular examples of that group, and any cross-reference in parenthesis is to the name of a group of substances within which the particular substance falls). Those in column 4 are cross-references to Annex II of the Directive, from which this Schedule is derived.
| (1) | (2) | (3) | (4) |
|---|---|---|---|
| Number in this Schedule | Name of substance | Cross-reference to this Schedule | Cross-reference to Annex II of the Directive |
| 1 | Acenocoumarol (INN) | 3 | 254 |
| 2 | 3-(α-Acetonylbenzyl)-4-hydroxycoumarin and its salts | 372, 704 | 203 |
| 3 | 3-(α-Acetonyl-p-nitrobenzyl)-4-hydroxycoumarin | 1 | 254 |
| 4 | 2-(or β-)Acetoxyethyltrimethylammonium hydroxide and its salts | 6 | 2 |
| 5 | 2-Acetylamino-5-chlorobenzoxazole | 151 | 1 |
| 6 | Acetylcholine and its salts | 4 | 2 |
| 7 | Acetylene chlorides | 227, 702 | 126 |
| 8 | Acetylenic alcohols, their esters, ethers and salts | 17 | 16 |
| 9 | Acetylethyltetramethyltetralin (AETT) | 317 | 362 |
| 10 | β-(7α-Acetylthio-17β-hydroxy-3-oxoandrost-4-en-17α-yl)propionic acid lactone | 599 | 4 |
| 11 | Aconitine and its salts | — | 12 |
| 12 | Aconitum napellus L.(leaves, roots and galenical preparations) | — | 11 |
| 13 | Adonis vernalis L. and its preparations | — | 13 |
| 14 | Adrenaline | 249, 294 | 14 |
| 15 | Alkali pentacyanonitrosylferrate (2-) | 563–4, 594–5 | 255 |
| 16 | O-Alkyldithiocarbonic acids, salts of | 705 | 336 |
| 17 | Alkyne alcohols, their esters, ethers and salts | 8 | 16 |
| 18 | Alloclamide (INN) and its salts | 22 | 19 |
| 19 | Allyl isothiocyanate | — | 18 |
| 20 | 2-(4-Allyl-2-methoxyphenoxy)—N,N-diethylacetamide and its salts | — | 224 |
| 21 | N-Allylnormorphine, its salts and ethers | 460 | 20 |
| 22 | 2-Allyloxy-4-chloro—N-[2'-(diethylamino)ethyl]benzamide and its salts | 18 | 19 |
| 23 | Alypine and its salts | 45, 103 | 143 |
| 24 | Ambenomium chloride (INN) | (492) | 132 |
| 25 | 4-(orp-)Aminobenzoic acid esters except glycerol 1-(4-aminobenzoate) when provisionally permitted for use as a UV filter in accordance with the requirements specified in item 4 of Part II of Schedule 5 | — | 167 |
| 26 | 2-Amino-1,2-bis(4-methoxyphenyl) ethanol and its salts | — | 29 |
| 27 | 3-Amino-4-butoxybenzoic acid 2-diethylaminoethyl ester and its salts | 95, 234 | 23 |
| 28 | Aminocaproic acid (INN) and its salts | 32 | 7 |
| 29 | 2-Amino-5-chlorobenzoxazole | 710 | 24 |
| 30 | 4-Amino—N-(2'-diethylaminoethyl) benzamide, its salts and derivatives | 566 | 23 |
| 31 | Aminoheptane, its isomers and salts | 695 | 27 |
| 32 | 6-Aminohexanoic acid and its salts | 28 | 7 |
| 33 | α-(Aminomethyl)-3,4-dihydroxybenzyl alcoholand its salts | 483, 484 | 257 |
| 34 | 4-Amino—N¹⁰-methylfolic acid | 425 | 6 |
| 35 | 2-Amino-6-methylheptane and its salts | 390, 489 | 28 |
| 36 | 2-Amino-4-methylhexane and its salts | 267, 442 | 30 |
| 37 | 2-Amino-4-nitrophenol | — | 383 |
| 38 | 2-Amino-5-nitrophenol | — | 384 |
| 39 | 4-(orp-)Aminosalicylic acid and its salts | — | 31 |
| 40 | Aminotoluenes, their isomers, salts and halogenated and sulphonated derivatives | 662 | 32 |
| 41 | Aminoxylenes, their isomers, salts and halogenated and sulphonated derivatives | 707 | 33 |
| 42 | Amitriptyline (INN) and its salts | 263 | 146 |
| 43 | Ammi majus and its galenical preparations | — | 35 |
| 44 | Amphetamine (INN), its salts and derivatives and salts of those derivatives | (625) | 21 |
| 45 | Amydricaine and its salts | 23, 103 | 143 |
| 46 | Amylene chloride | 228 | 36 |
| 47 | Amyl 4-dimethylaminobenzoate, mixed isomers (Padimate A (INN)) | 496 | 381 |
| 48 | Amyl nitrites | — | 247 |
| 49 | Amylobarbitone and its salts | (68) | 220 |
| 50 | Amylocaine and its salts | 261 | 50 |
| 51 | Anamirta cocculus L.(fruit) | — | 106 |
| 52 | Substances with androgenic effect | — | 37 |
| 53 | Aniline, its salts and halogenated and sulphonated derivatives | — | 22 |
| 54 | Anthracene oil | — | 38 |
| 55 | Antibiotics (except tyrothricin) | — | 39 |
| 56 | Antimony and its compounds | — | 40 |
| 57 | Apocynum cannabinum L. and its preparations | — | 41 |
| 58 | Apomorphine and its salts | 641 | 42 |
| 59 | Apronalide | 393 | 216 |
| 60 | Arecoline | 451 | 238 |
| 61 | Aristolochic acid and its salts | — | 365 |
| 62 | Arsenic and its compounds | — | 43 |
| 63 | Atropa belladonna L. and its compounds | — | 44 |
| 64 | Atropine, its salts and derivatives | — | 45 |
| 65 | Azacyclonol (INN) and its salts | 285 | 286 |
| 66 | Azamethonium bromide (INN) | 443 | 121 |
| 67 | Barbitone and its salts | (68) | 220 |
| 68 | Barbiturates | various | 220 |
| 69 | Barium salts (except barium sulphate, barium sulphide under the condition laid down in Part I of Schedule 2, for alkaline earth sulphides and lakes, salts and pigments prepared from those colouring agents identified in Column 1 of Schedule 3 by “*” immediately after the name or colour index number) | — | 46 |
| 70 | Bemegride (INN) and its salts | 311, 312 | 183 |
| 71 | Benactyzine (INN) | 235 | 157 |
| 72 | Bendrofluazide and its derivatives | 73, 86 | 53 |
| 73 | Bendroflumethiazide (INN) and its derivatives | 72, 86 | 53 |
| 74 | Benzamine and its salts | 688 | 51 |
| 75 | Benzatropine (INN) and its salts | 281 | 158 |
| 76 | Benzazepines, their salts and derivatives | 85 | 49 |
| 77 | Benzene | — | 47 |
| 78 | 2-Benzhydryloxyethyldimethylamine and its salts | 276 | 339 |
| 79 | Benzidine | 221 | 26 |
| 80 | Benzilonium bromide (INN) | 90 | 60 |
| 81 | 2-Benziloyloxymethyl-1,1-dimethylpyrrolidinium methylsulphate | 561 | 239 |
| 82 | Benzimidazolone | 83, 244 | 48 |
| 83 | Benzimidazol-2(3H)-one | 82, 244 | 48 |
| 84 | Benzoates of 4-hydroxy-3-methoxycinnamyl alcohol (except natural content of essences) | 191 | 357 |
| 85 | Benzodiazepines, their salts and derivatives | 76 | 49 |
| 86 | Benzothiadiazine and its derivatives | 72, 73 | 53 |
| 87 | Benzoyl peroxide | — | 382 |
| 88 | 3-(N-Benzylhydrazinocarbonyl)-5-methylisoxazole | 387 | 52 |
| 89 | Benzylideneacetone | 527 | 356 |
| 90 | 3-Benzyloxy-1,1-diethylpyrrolidine hydrobromide | 80 | 60 |
| 91 | 4-Benzyloxyphenol | (366, 456) | 178 |
| 92 | 2-[Benzyl—N-(2-pyridyl)amino]-ethyldimethylamine | 581, 692 | 347 |
| 93 | Beryllium and its compounds | — | 54 |
| 94 | Betamethasone (INN) | (337) | 300 |
| 95 | Betoxycaine (INN) and its salts | 27, 95, 234 | 23 |
| 96 | BHC (ISO) (gamma-BHC) | 346, 348, 401 | 195 |
| 97 | Bietamiverine (INN) | 238 | 287 |
| 98 | 1,6-Bis(2-chloroethylamino)-1,6-dideoxymannitol and its salts | 409 | 89 |
| 99 | 2-[Bis(2-chloroethyl)amino]-1-oxa-3-aza-2-phosphacyclohexane 2-oxide and its salts | 102, 211 | 88 |
| 100 | N,N-Bis(2-chloroethyl)methylamine and its salts | 148, 458 | 87 |
| 101 | N,N-Bis(2-chloroethyl)methylamine N-oxide and its salts | 459 | 86 |
| 102 | N,N-Bis(2-chloroethyl)—N',O-propylenephosphoramide anhydride and its salts | 99, 211 | 88 |
| 103 | 1,1-Bis(dimethylaminomethyl)propyl benzoate and its salts | 23, 45 | 143 |
| 104 | 2,2-Bis(hydroxymethyl)butan-1-ol trinitrate | 572 | 206 |
| 105 | 2,6-Bis(β-hydroxyphenethyl)-1-methylpiperidine and its salts | 403 | 219 |
| 106 | Bithionol (INN) | 651 | 352 |
| 107 | Bretylium tosilate (INN) (or tosylate) | 110 | 56 |
| 108 | Bromine, elemental | — | 55 |
| 109 | Bromisoval (INN) | 113 | 58 |
| 110 | p-Bromobenzylethyldimethylammoniump-toluenesulphonate | 107 | 56 |
| 111 | Bromodiethylacetylurea | 112, 139 | 57 |
| 112 | α-Bromo-α-ethylbutyrylurea | 111, 139 | 57 |
| 113 | Bromoisovalerylurea | 109 | 58 |
| 114 | 1—p-bromophenyl-1-(2-pyridyl)-3-dimethylaminopropane and its salts | 115 | 59 |
| 115 | Brompheniramine (INN) and its salts | 114 | 59 |
| 116 | Brucine | — | 62 |
| 117 | Butanilicaine (INN) and its salts | 438 | 90 |
| 118 | Butobarbitone and its salts | (68) | 220 |
| 119 | Butopiprine (INN) and its salts | 121 | 288 |
| 120 | 2-Butoxy—N-(2-diethylaminoethyl) cinchoninamide and its salts | 178 | 129 |
| 121 | 2-Butoxyethyl α-phenyl-α-(N-piperidino)acetate and its salts | 119 | 288 |
| 122 | 1-Butyl-3-(N-crotonoylsulphanilyl) urea | — | 108 |
| 123 | 4-Butyl-1,2-diphenylpyrazolidine-3,5-dione | 526 | 67 |
| 124 | 4-Butyl-1-phenylpyrazolidine-3,5-dione | 455 | 64 |
| 125 | 1-Butyl-3-(p-methylbenzenesulphonyl) urea | 661 | 65 |
| 126 | 1-Butyl-3-sulphanilylurea | 140 | 66 |
| 127 | 4-Butylthiobenzohydryl dimethylaminoethyl sulphide | 133 | 140 |
| 128 | Cadmium and its compounds | — | 68 |
| 129 | Calabar bean | 547 | 281 |
| 130 | Cantharides,Cantharis vesicatoria | 597 | 69 |
| 131 | Cantharidin | 354 | 70 |
| 132 | Captan (ISO) | 680 | 370 |
| 133 | Captodiame (INN) | 127 | 140 |
| 134 | Caramiphen (INN) and its salts | 530 | 169 |
| 135 | N-(3-Carbamoyl-3,3-diphenylpropyl)—N,N-diisopropylmethylammonium salts | 392 | 156 |
| 136 | Carbazole, nitroderivatives of | 476 | 72 |
| 137 | Carbon disulphide | — | 73 |
| 138 | Carbon tetrachloride | 637 | 315 |
| 139 | Carbromal (INN) | 111, 112 | 57 |
| 140 | Carbutamide (INN) | 126 | 66 |
| 141 | Carisoprodol (INN) | 449 | 235 |
| 142 | Catalase | — | 74 |
| 143 | Cephaeline and its salts | — | 75 |
| 144 | Chenopodium ambrosioides(essential oil) | — | 76 |
| 145 | Cherry laurel water | 577 | 291 |
| 146 | Chloral hydrate | 677 | 77 |
| 147 | Chlorine | — | 78 |
| 148 | Chlormethine (INN) and its salts | 100,458 | 87 |
| 149 | Chlormezanone (INN) | 162 | 91 |
| 150 | 5-Chlorobenzoxazolinone | 173 | 82 |
| 151 | N-5-Chlorobenzoxazol-2-ylacetamide | 5 | 1 |
| 152 | 2-Chloro-4-dimethylamino-6-methylpyrimidine | 157, 196 | 83 |
| 153 | 2-Chloro-9-(α-dimethylamino-propylidine)thioxanthene (trans-form) and its salts | 170 | 84 |
| 154 | 4-Chloro-1,3-disulphamoylbenzene | 181 | 85 |
| 155 | Chloroethane | 305 | 96 |
| 156 | Chloroform | 679 | 366 |
| 157 | 2-Chloro-6-methylpyrimidin-4-yldimethylamine | 152, 196 | 83 |
| 158 | Chlorophacinone (ISO) | 163 | 93 |
| 159 | 1-(p-Chloro-α-phenylbenzyl)-4-(2-hydroxyethoxyethyl)piperazine | 376 | 240 |
| 160 | 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one | 345 | 185 |
| 161 | 2-(4-Chlorophenyl)-3-methylbutane-2,3-diol | 516 | 95 |
| 162 | 2-(4-Chlorophenyl-3-methyl-4-metathiazonone-1,1-dioxide | 149 | 91 |
| 163 | 2-[2-(4-Chlorophenyl)-2-phenylacetyl]indan-1,3-dione | 158 | 93 |
| 164 | 1-(4-Chlorophenyl)-1-phenyl-1-dimethylaminoethoxyethane | 167 | 94 |
| 165 | Chloropicrine | — | 325 |
| 166 | 3-(4-Chloro-3-sulphamoylphenyl)-3-hydroxyisoindolin-1-one | 171, 172 | 262 |
| 167 | Chlorphenoxamine (INN) | 164 | 94 |
| 168 | Chlorpromazine (INN) | (521) | 320 |
| 169 | Chlorpropamide (INN) | 573 | 79 |
| 170 | Chlorprothixene (INN) and its salts | 153 | 84 |
| 171 | Chlortalidone (INN) | 166, 172 | 262 |
| 172 | Chlorthalidone | 166, 171 | 262 |
| 173 | Chlorzoxazone (INN) | 150 | 82 |
| 174 | Cholecalciferol | (703) | 335 |
| 175 | Choline salts and their esters | — | 168 |
| 176 | Chromium, chromic acid and salts of the acid | — | 97 |
| 177 | Chrysoidine citrate hydrochloride | 525 | 81 |
| 178 | Cinchocaine (INN) and its salts | 120 | 129 |
| 179 | Cincophen (INN), its salts and derivatives and salts of those derivatives | 539 | 8 |
| 180 | Claviceps purpurea Tul., its alkaloids and galenical preparations | 296 | 98 |
| 181 | Clofenamide (INN) | 154 | 85 |
| 182 | Clofenotane (INN) | 213, 676 | 123 |
| 183 | Cobalt benzenesulphonate | — | 101 |
| 184 | Cocculin | 551 | 282 |
| 185 | Colchicine, its salts and derivatives | — | 102 |
| 186 | Colchicoside and its derivatives | — | 103 |
| 187 | Colchicum autumnale L. and its galenical preparations | — | 104 |
| 188 | Colouring agent CI 12140 | — | 378 |
| 189 | Colouring agent CI 26105 | — | 379 |
| 190 | Colouring agents CI 42555, 42555–1 and 42555–2 | — | 380 |
| 191 | Coniferyl benzoate (except natural content of essences) | 84 | 357 |
| 192 | Coniine | 574 | 290 |
| 193 | Conium maculatum L. (fruit, powder, galenical preparations) | — | 99 |
| 194 | Convallatoxin | — | 105 |
| 195 | Coumetarol (INN) | 427 | 225 |
| 196 | Crimidine (ISO) | 152, 157 | 83 |
| 197 | Croton tiglium(oil) | — | 107 |
| 198 | Curare and curarine | — | 109 |
| 199 | Curarizants, synthetic | — | 110 |
| 200 | Cyanides | 363, 365 | 111 |
| 201 | 1-(3-Cyano-3,3-diphenylpropyl)-4-phenyl-4-piperidinecarboxylic acid ethyl ester hydrochloride | 277 | 80 |
| 202 | Cyclarbamate (INN) | 210 | 122 |
| 203 | Cyclizine (INN) and its salts | 282 | 159 |
| 204 | Cyclobarbitone and its salts | (68) | 220 |
| 205 | Cyclocoumarol | 245 | 234 |
| 206 | 2-α-Cyclohexylbenzyl(N,N,N',N'-tetraethyl)trimethylenediamine | 517 | 112 |
| 207 | 2-Cyclohexyl-3,5-dimethylphenol and its salts | 209 | 113 |
| 208 | 1-Cyclohexyl-3-(p-methylbenzenesulphonyl)urea | 340 | 100 |
| 209 | Cyclomenol (INN) and its salts | 207 | 113 |
| 210 | Cyclopentane-1,1-dimethanol dicarbanilate | 202 | 122 |
| 211 | Cyclophosphamide (INN) and its salts | 99, 102 | 88 |
| 212 | Datura stramonium L. and its galenical preparations | 601 | 301 |
| 213 | DDT (ISO) (p,p'-DDT) | 182, 676 | 123 |
| 214 | Deanol aceglumate (INN) | 256 | 3 |
| 215 | Decamethonium bromide (INN) | 216 | 214 |
| 216 | Decamethylenebis(trimethylammonium) salts | 215 | 214 |
| 217 | Dextromethorphan (INN) and its salts | 430 | 226 |
| 218 | Dextropropoxyphene (INN) | 260 | 116 |
| 219 | O,O'-Diacetyl-N-allyl—N-normorphine | — | 117 |
| 220 | 1,2-Diaminobenzene and its salts | 533 | 363 |
| 221 | p,p'-Diaminodiphenyl | 79 | 26 |
| 222 | 1,4:3,6-Dianhydrosorbitol 2,5-dinitrate | 395 | 148 |
| 223 | 5-(α, β-Dibromophenethyl)-5-methylhydantoin | — | 119 |
| 224 | Dibromosalicylanilides | 225, 416 | 351 |
| 225 | Dibromsalan (INN) | (224) | 351 |
| 226 | Dichloroethanes | 306, 309 | 125 |
| 227 | Dichloroethylenes | 7, 702 | 126 |
| 228 | 2,3-Dichloro-2-methylbutane | 46 | 36 |
| 229 | Dichlorosalicylanilides | — | 349 |
| 230 | Dicoumarin | 231, 440 | 231 |
| 231 | Dicoumarol (INN) | 230, 440 | 231 |
| 232 | 2-(Diethylaminoethoxy)ethyl α-phenylpiperidine-1-acetate dimethiodide | 560 | 137 |
| 233 | 1-[4-(β-Diethylaminoethoxy)phenyl]-1-(4-tolyl)-2-(4-chlorophenyl)-ethanol | 691 | 92 |
| 234 | 2-Diethylaminoethyl 3-amino-4-butoxybenzoate and its salts | 27, 95 | 23 |
| 235 | 2-Diethylaminoethyl benzilate and its salts | 71 | 157 |
| 236 | 2-Diethylaminoethyl 4-ethoxybenzoate and its salts | 383, 500 | 179 |
| 237 | 2-Diethylaminoethyl 3-hydroxy-4-phenylbenzoate and its salts | — | 128 |
| 238 | 2-Diethylaminoethyl α-phenyl-α-(N-piperidino)acetate | 97 | 287 |
| 239 | 3-Diethylaminopropyl cinnamate | — | 130 |
| 240 | Diethyl 4-nitrophenyl phosphate | 498 | 170 |
| 241 | O,O-DiethylO-4-nitrophenyl phosphorothioate | 499 | 131 |
| 242 | Difencloxazine (INN) | 529 | 270 |
| 243 | Digitaline and all heterosides ofDigitalis purpurea L. | — | 134 |
| 244 | 4,5-Dihydrobenzimidazol-4-one | 82, 83 | 48 |
| 245 | 3,4-Dihydro-2-methoxy-2-methyl-4-phenyl-2H, 5H-pyrano [3,2—c]-[1]-benzopyran-5-one | 205 | 234 |
| 246 | Dihydrotachysterol (INN) | — | 342 |
| 247 | 2,2'-Dihydroxy-3,3',5,5'6,6'-hexachlorodiphenylmethane (hexachlorophene) | 351 | 371 |
| 248 | 3,4-Dihydroxy-α-(isopropylaminomethyl)benzyl alcohol | 391, 394 | 17 |
| 249 | 3,4-Dihydroxy-α-(methylaminomethyl)benzyl alcohol | 14, 294 | 14 |
| 250 | 4,4'-Dihydroxy-3,3'-(3-methylthiopropylidene)dicoumarin | — | 207 |
| 251 | 1-(3,4-Dihydroxyphenyl)-2-ethylaminopropan-1-ol | 274 | 136 |
| 252 | 5,5'-Di-isopropyl-2,2'-dimethylbiphenyl-4,4'-diyl dihypoiodite | 385 | 361 |
| 253 | Dimethoxane | 265 | 368 |
| 254 | 4-[β-(3,4-Dimethoxyphenyl)ethyl]-1-(2-chlorophenyl)piperazine and its salts | 411 | 141 |
| 255 | Dimethylamine | — | 142 |
| 256 | 2-DimethylaminoethylN-acetylglutamate | 214 | 3 |
| 257 | 2-[α-(2-Dimethylaminoethoxy)-α-methylbenzyl]pyridine and its salts | 290 | 176 |
| 258 | 2-Dimethylaminoethylp-butylaminobenzoate and its salts | 634 | 63 |
| 259 | 2-[(2-Dimethylaminoethyl)-2-thienylamino]pyridine and its salts | 421 | 144 |
| 260 | (+)-4-Dimethylamino-3-methyl-1,2-diphenyl-2-propionyloxybutane | 218 | 116 |
| 261 | 1-Dimethylaminomethyl-1-methylpropyl benzoate and its salts | 50 | 50 |
| 262 | 2-Dimethylaminopropiophenone and its salts | 418 | 145 |
| 263 | 3-(3-Dimethylaminopropylidene)-1,2:4,5-dibenzocyclohepta-1,4-diene and its salts | 42 | 146 |
| 264 | N,N-Dimethyldiguanide and its salts | 420 | 147 |
| 265 | 2,6-Dimethyl-1,3-dioxan-4-yl acetate (Dimethoxane) | 253 | 368 |
| 266 | Dimethylformamide | — | 355 |
| 267 | 1,3-Dimethylpentylamine and its salts | 36, 442 | 30 |
| 268 | 1,2-Dimethyl-4-phenyl-4-carbmethoxyhexamethyleneimine and its salts | 422 | 174 |
| 269 | 1,3-Dimethyl-4-phenyl-4-carboxyethylhexamethyleneimine and its salts | 419 | 171 |
| 270 | Dimethyl sulphoxide (INN) | — | 338 |
| 271 | Dimevamide (INN) and its salts | 278 | 153 |
| 272 | Dinitrophenol isomers | — | 151 |
| 273 | Dioxane | — | 343 |
| 274 | Dioxethedrin (INN) and its salts | 251 | 136 |
| 275 | 2,5-Dioxo-3,3-diethyl-5-methylpiperidine and its salts | 452 | 133 |
| 276 | Diphenhydramine (INN) and its salts | 78 | 339 |
| 277 | Diphenoxylate hydrochloride (INNM) | 201 | 80 |
| 278 | 2,2-Diphenyl-4-dimethylamino-valeramide and its salts | 271 | 153 |
| 279 | 5,5-Diphenyl-4-imidazolidone | — | 160 |
| 280 | 4-Diphenylmethoxy-1-methylpiperidine and its salts | 286 | 154 |
| 281 | 3-Diphenylmethoxytropane and its salts | 75 | 158 |
| 282 | 1-Diphenylmethyl-4-methylpiperazine | 203 | 159 |
| 283 | 1,2-Diphenyl-4-(2-phenylsulphinylethyl)pyrazolidine-3,5-dione | 608 | 155 |
| 284 | α,α-Diphenyl-2-piperidinemethanol | 559 | 285 |
| 285 | α,α-Diphenyl-4-piperidinemethanol | 65 | 286 |
| 286 | Diphenylpyraline (INN) and its salts | 280 | 154 |
| 287 | 2,5-Dipropoxy-3,6-bis(ethyleneimino)-1,4-benzoquinone | 382 | 152 |
| 288 | 4-Dipropylsulphamylbenzoic acid | 565 | 161 |
| 289 | Disulfiram (INN) | 645, 656 | 162 |
| 290 | Doxylamine (INN) and its salts | 257 | 176 |
| 291 | Emetine, its salts and derivatives | — | 163 |
| 292 | Endrin (ISO) | 349 | 196 |
| 293 | Ephedrine and its salts | — | 164 |
| 294 | Epinephrine (INN) | 14, 249 | 14 |
| 295 | Ergocalciferol (INN) | (703) | 335 |
| 296 | Ergot, its alkaloids and galenical preparations | 180 | 98 |
| 297 | Eserine and its salts | 548 | 166 |
| 298 | Ethionamide (INN) | 310 | 319 |
| 299 | Ethoheptazine (INN) and its salts | 446 | 173 |
| 300 | Ethopropazine and its salts | (521) | 320 |
| 301 | 4-Ethoxyphenol | (366, 456) | 178 |
| 302 | 2-Ethylamino-5-phenyloxazolin-4-one | 319 | 180 |
| 303 | Ethyl bis(4-hydroxycoumarinyl)-acetate and salts of the acid | 304 | 204 |
| 304 | Ethyl bis(4-hydroxy-2-oxo-1-benzopyran-3-yl)acetate and salts of the acid | 303 | 204 |
| 305 | Ethyl chloride | 155 | 96 |
| 306 | Ethylene dichloride | (226) | 125 |
| 307 | Ethylene oxide | — | 182 |
| 308 | 2-Ethyl-2,3-epoxyhexamide and its derivatives | 493 | 165 |
| 309 | Ethylidene chloride | (226) | 125 |
| 310 | 3-Ethylisothionicotinamide | 298 | 319 |
| 311 | β-Ethyl-β-methylglutarimide and its salts | 70, 312 | 183 |
| 312 | 4-Ethyl-4-methylpiperidine-2,6-dione and its salts | 70, 311 | 183 |
| 313 | β-Ethyl-β-methylvaleramide | 698 | 184 |
| 314 | Ethylphenacemide (INN) | 528 | 272 |
| 315 | 2-Ethyl-2-phenylglutarimide and its salts | 316, 338 | 181 |
| 316 | 3-Ethyl-3-phenylpiperidine-2,6-dione and its salts | 315, 338 | 181 |
| 317 | 3'-Ethyl-5',6',7',8'-tetrahydro-5',5',8',8'-tetramethyl-2'-acetonaphthone | 9 | 362 |
| 318 | Fenadiazole (INN) | 374 | 208 |
| 319 | Fenozolone (INN) | 302 | 180 |
| 320 | Fenyramidol (INN) | 538, 541 | 274 |
| 321 | Fluanisone (INN) | 326 | 187 |
| 322 | Fluoresone (INN) | 325 | 189 |
| 323 | 4'-Fluoro-4-[4-hydroxy-4-(α,α,α-trifluoro—m-tolyl)piperidino]-butyrophenone | 685 | 188 |
| 324 | 6-Fluoro-16-methyl-11β,17α,21-trihydroxypregna-1,4-diene-3,20-dione | 497 | 186 |
| 325 | p-Fluorophenylethylsulphone | 322 | 189 |
| 326 | 1-(4-Fluorophenyl)-4-[4-(2-methoxyphenyl)-1-piperazinyl]-butan-1-one | 321 | 187 |
| 327 | 5-Fluoropyrimidine-2,4-dione | 328 | 190 |
| 328 | Fluorouracil (INN) | 327 | 190 |
| 329 | Fluphenazine (INN) | (521) | 320 |
| 330 | Furazolidone (INN) | 479 | 252 |
| 331 | Furfuryltrimethylammonium salts | 334 | 192 |
| 332 | Furo[3,2—g]chromen-7-one and its alkyl-substituted derivatives (except natural content of essences) | 333, 434, 690 | 358 |
| 333 | Furocoumarin and its alkyl-substituted derivatives (except natural content of essences) | 332, 434, 690 | 358 |
| 334 | Furtrethonium iodide (INN) | 331 | 192 |
| 335 | Galantamine (INN) | — | 193 |
| 336 | Gallamine triethiodide (INN) | 693 | 329 |
| 337 | Glucocorticoids | 94 | 300 |
| 338 | Glutethimide (INN) and its salts | 315, 316 | 181 |
| 339 | Glycerol trinitrate | 480, 571 | 253 |
| 340 | Glycyclamide (INN) | 208 | 100 |
| 341 | Gold salts | — | 296 |
| 342 | Guaifenesin (INN) | 432 | 230 |
| 343 | Guanethidine (INN) and its salts | 344 | 259 |
| 344 | N-(2-Guanidinoethyl)heptamethyleneimine and its salts | 343 | 259 |
| 345 | Haloperidol (INN) | 160 | 185 |
| 346 | HCH (ISO) (gamma-HCH) | 96, 348, 401 | 195 |
| 347 | HETP | 353 | 316 |
| 348 | 1,2,3,4,5,6-Hexachlorocyclohexane | 96, 346, 401 | 195 |
| 349 | (1R, 4S, 5R, 8S)-1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene | 292 | 196 |
| 350 | Hexachloroethane | — | 197 |
| 351 | Hexachlorophene (INN) | 247 | 371 |
| 352 | (1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene | 388 | 198 |
| 353 | Hexaethyl tetraphosphate | 347 | 316 |
| 354 | (1R,2S)-Hexahydro-1,2-dimethyl-3,6-epoxyphthalic anhydride | 131 | 70 |
| 355 | (3S,5aR,9bS)-3,3a,4,5,5a,9b-Hexahydro-3,5a,9-trimethylnaphtho-[1,2-b]furan-2,8-dione | 587 | 217 |
| 356 | Hexamethonium bromide (INN) | (357) | 124 |
| 357 | N,N'-Hexamethylenebis(trimethylammonium) salts | 356 | 124 |
| 358 | Hexapropymate (INN) | 575 | 115 |
| 359 | Hydrastine, hydrastinine and their salts | — | 199 |
| 360 | Hydrazides and their salts | — | 200 |
| 361 | Hydrazine, its derivatives and their salts | — | 201 |
| 362 | 2-Hydrazino-octane and its salts | 487 | 202 |
| 363 | Hydrocyanic acid and its salts | 200, 365 | 111 |
| 364 | Hydrofluoric acid, its normal salts, complexes and hydrofluorides (except those listed in Part I of Schedule 2) | — | 191 |
| 365 | Hydrogen cyanide and its salts | 200, 363 | 111 |
| 366 | Hydroquinone monobenzyl, monoethyl and monomethyl ethers | 91, 301, 431, (456) | 178 |
| 367 | 7-[2-Hydroxy-3-(2-hydroxyethyl—N-methylamino)propyl]theophylline | 706 | 135 |
| 368 | [4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid and its salts | 686 | 5 |
| 369 | 3-[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propionic acid and its salts | 659 | 9 |
| 370 | 1-Hydroxymethyl-1-cyclohexylacetic acid, sodium salt | 593 | 114 |
| 371 | 8-Hydroxy-5(or 6)-nitroquinoline and its salts | 482 | 209 |
| 372 | 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-coumarin and its salts | 2, 704 | 203 |
| 373 | 1-(4-Hydroxy-β-phenylethyl)-4-phenyl-4-carbethoxypiperidine and its salts | 495 | 172 |
| 374 | 2-(4-Hydroxyphenyl-1,3,4-oxadiazole | 318 | 208 |
| 375 | 1-Hydroxy-2,4,6-trinitrobenzene | 550, 689 | 268 |
| 376 | Hydroxyzine (INN) | 159 | 240 |
| 377 | Hyoscine, its salts and derivatives | 590 | 295 |
| 378 | Hyoscyamine, its salts and derivatives | — | 210 |
| 379 | Hyoscyamus niger L(leaves, seeds powder and galenical preparations) | — | 211 |
| 380 | 2-Imino-5-phenyloxazolidin-4-one and its salts | 502 | 212 |
| 381 | Imperatorin | 437 | 34 |
| 382 | Inproquone (INN) | 287 | 152 |
| 383 | Intracaine and its salts | 236, 500 | 179 |
| 384 | Iodine | — | 213 |
| 385 | Iodothymol | 252 | 361 |
| 386 | Ipecacuanha (Cephaelis ipecacuanha Brot. and related species) (roots, powder and galenical preparations) | — | 215 |
| 387 | Isocarboxazid (INN) | 88 | 52 |
| 388 | Isodrin | 352 | 198 |
| 389 | Isometheptene (INN) and its salts | 435 | 228 |
| 390 | 2-Isooctylamine and its salts | 35, 489 | 28 |
| 391 | Isoprenaline (INN) | 248, 394 | 17 |
| 392 | Isopropamide iodide (INN) | 135 | 156 |
| 393 | (2-Isopropylpent-4-enoyl)urea | 59 | 216 |
| 394 | Isoproterenol | 248, 391 | 17 |
| 395 | Isosorbide dinitrate (INN) | 222 | 148 |
| 396 | Juniperus sabina L. (leaves, essential oil and galenical preparations) | — | 294 |
| 397 | Laurel oil | 398 | 359 |
| 398 | Laurus nobilis L. (oil from seeds) | 397 | 359 |
| 399 | Lead and its compounds (except lead acetate) | — | 289 |
| 400 | Levophacetoperane and its salts | 556 | 284 |
| 401 | Lindane | 96, 346, 348 | 195 |
| 402 | Lobelia inflata L. and its galenical preparations | — | 218 |
| 403 | Lobeline (INN) and its salts | 105 | 219 |
| 404 | LSD | 406, 407 | 127 |
| 405 | Lupinidine and its salts | 598 | 299 |
| 406 | Lysergic acid diethylamide and its salts | 404, 407 | 127 |
| 407 | Lysergide (INN) and its salts | 404, 406 | 127 |
| 408 | Malononitrile | — | 149 |
| 409 | Mannomustine (INN) and its salts | 98 | 89 |
| 410 | Mecamylamine (INN) | 644 | 229 |
| 411 | Mefeclorazine (INN) and its salts | 254 | 141 |
| 412 | Mephenesin (INN) and its esters | 664 | 322 |
| 413 | Meprobamate (INN) | 450 | 236 |
| 414 | Mercury and its compounds (except those listed in Part III of Schedule 2 or in Part I of Schedule 4) | — | 221 |
| 415 | Mescaline and its salts | 687 | 222 |
| 416 | Metabromsalan (INN) | (224) | 351 |
| 417 | Metaldehyde | 562 | 223 |
| 418 | Metamfepramone (INN) and its salts | 262 | 145 |
| 419 | Metethoheptazine (INN) and its salts | 269 | 171 |
| 420 | Metformin (INN) and its salts | 264 | 147 |
| 421 | Methapyrilene (INN) and its salts | 259 | 144 |
| 422 | Metheptazine (INN) and its salts | 268 | 174 |
| 423 | Methocarbamol (INN) | 433 | 205 |
| 424 | Methohexitone and its salts | (68) | 220 |
| 425 | Methotrexate (INN) | 34 | 6 |
| 426 | 2-[4-Methoxybenzyl—N-(2-pyridyl)amino]ethyldimethylamine maleate | 580 | 346 |
| 427 | 1-Methoxy-2,2-bis(4-hydroxy-3-coumarinyl)ethane | 195 | 225 |
| 428 | 1-Methoxy-2,4-diaminobenzene (2,4-diaminoanisole-CI 76050) | — | 376 |
| 429 | 1-Methoxy-2,5 diaminobenzene (2,5-diaminoanisole) | — | 377 |
| 430 | (+)-3-Methoxy—N-methylmorphinan and its salts | 217 | 226 |
| 431 | 4-Methoxyphenol | (366, 456) | 178 |
| 432 | 3-(4-Methoxyphenoxy)propane-1,2-diol | 342 | 230 |
| 433 | 3-(2-Methoxyphenoxy)propane-1,2-diol 1-carbamate | 423 | 205 |
| 434 | 8-Methoxypsoralen (except natural content of essences) | 332, 333, 690 | 358 |
| 435 | 6-Methylamino-2-methylhept-2-ene and its salts | 389 | 228 |
| 436 | 2-Methyl-1,2-bis(3-pyridyl)-propan-1-one | 453 | 292 |
| 437 | 9-(3-Methylbut-2-enyloxy)furo-[3,2—g]chromen-7-one | 381 | 34 |
| 438 | 2-Methyl-6-chloroanilide of n-butylaminoacetic acid and its salts | 117 | 90 |
| 439 | 1-Methyl-2,4-diaminobenzene and its salts | 447 | 364 |
| 440 | 3,3-Methylenebis-(4-hydroxycoumarin) | 230, 231 | 231 |
| 441 | 2-Methylheptylamine and its salts | — | 227 |
| 442 | 4-Methyl-2-hexylamine and its salts | 36, 267 | 30 |
| 443 | N,N'-[(Methylimino)diethylene]bis-(ethyldimethylammonium) salts | 66 | 121 |
| 444 | 1-Methyl-2-mercaptoimidazole | 650 | 233 |
| 445 | Methylphenidate (INN) and its salts | 535 | 175 |
| 446 | 1-Methyl-4-phenyl-4-carbethoxyhexamethyleneimine and its salts | 299 | 173 |
| 447 | 4-Methyl—m-phenylenediamine and its salts | 439 | 364 |
| 448 | 3-Methyl-2-phenylmorpholine, its derivatives and salts | 519 | 232 |
| 449 | 2-Methyl-2-propyl-1-isopropylcarbamoyloxy-3-carbamoyloxypropane | 141 | 235 |
| 450 | 2-Methyl-2-propylpropane-1,3-diol dicarbamate | 413 | 236 |
| 451 | N-Methyl-1,2,5,6-tetrahydro-3-nicotinic acid methyl ester | 60 | 238 |
| 452 | Methyprylon (INN) and its salts | 275 | 133 |
| 453 | Metyrapone (INN) | 436 | 292 |
| 454 | Minoxidil (INN), its salts and derivatives | 558 | 372 |
| 455 | Mofebutazone (INN) | 124 | 64 |
| 456 | Monobenzone (INN) | 91, 301, (366) 431 | 178 |
| 457 | Morpholine and its salts | — | 344 |
| 458 | Mustine and its salts | 100, 148 | 87 |
| 459 | MustineN-oxide and its salts | 101 | 86 |
| 460 | Nalorphine (INN), its salts and ethers | 21 | 20 |
| 461 | Naphazoline (INN) and its salts | 467 | 244 |
| 462 | 2-Naphthol | 463 | 241 |
| 463 | β-Naphthol | 462 | 241 |
| 464 | 1-and 2-Naphthylamines and their salts | 465 | 242 |
| 465 | α-and β-Naphthylamines and their salts | 464 | 242 |
| 466 | 3-(1-Naphthyl)-4-hydroxycoumarin | — | 243 |
| 467 | 2-(1-Naphthylmethyl)imidazoline and its salts | 461 | 244 |
| 468 | Narcotics, natural and synthetic: All substances listed in Tables I and II of the Single Convention on Narcotic Drugs 1961 (Treaty Series No. 34(1965), Cmnd. 2631) | — | 306 |
| 469 | Narcotine and its salts | 485 | 258 |
| 470 | Neodymium and its salts | — | 309 |
| 471 | Neostigmine and its salts | — | 245 |
| 472 | Nicotine and its salts | — | 246 |
| 473 | Nitrites, inorganic (except sodium nitrite) | — | 248 |
| 474 | Nitrobenzene | — | 249 |
| 475 | Nitrocresols and their alkali metal salts | — | 250 |
| 476 | Nitroderivatives of carbazole | 136 | 72 |
| 477 | Nitrofurantoin (INN) | 478 | 251 |
| 478 | N-(5-Nitro-2-furfurylidene)-1-aminohydantoin | 477 | 251 |
| 479 | 3-(5-Nitrofurfurylideneamino)-oxazolidin-2-one | 330 | 252 |
| 480 | Nitroglycerine | 339, 571 | 253 |
| 481 | Nitrostilbenes, their homologues and derivatives | — | 256 |
| 482 | Nitroxoline (INN) and its salts | 371 | 209 |
| 483 | Noradrenaline and its salts | 33, 484 | 257 |
| 484 | Norepinephrine and its salts | 33, 483 | 257 |
| 485 | Noscapine (INN) and its salts | 469 | 258 |
| 486 | Nux vomica and its preparations | 605 | 305 |
| 487 | Octamoxin (INN) and its salts | 362 | 202 |
| 488 | Octamylamine (INN) and its salts | 510 | 267 |
| 489 | Octodrine (INN) and its salts | 35, 390 | 28 |
| 490 | Oestrogens | — | 260 |
| 491 | Oleandrin | — | 261 |
| 492 | [Oxalylbis(iminoethylene)]bis-[(o-chlorobenzyl)diethylammonium] salts | 24 | 132 |
| 493 | Oxanamide (INN) and its derivatives | 308 | 165 |
| 494 | 2-Oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzo-[a]quinolizine and its salts | 632 | 139 |
| 495 | Oxpheneridine (INN) and its salts | 373 | 172 |
| 496 | Padimate A | 47 | 381 |
| 497 | Paramethasone (INN) | 324 | 186 |
| 498 | Paraoxon | 240 | 170 |
| 499 | Parathion (ISO) | 241 | 131 |
| 500 | Parethoxycaine (INN) and its salts | 236, 383 | 179 |
| 501 | Pelletierine and its salts | 557 | 263 |
| 502 | Pemoline (INN) and its salts | 380 | 212 |
| 503 | Pentachloroethane | — | 264 |
| 504 | Pentaerythritol chloral | 514 | 266 |
| 505 | Pentaerythritol tetranitrate | 506, 513 | 265 |
| 506 | Pentaerythrityl tetranitrate (INN) | 505, 513 | 265 |
| 507 | Pentamethonium bromide (INN) | 508 | 120 |
| 508 | N,N'-Pentamethylenebis-(trimethylammonium) salts | 507 | 120 |
| 509 | Pentobarbitone and its salts | 68 | 220 |
| 510 | Pentylaminomethylheptane, its isomers and salts | 488 | 267 |
| 511 | Perchloroethylene | 636 | 314 |
| 512 | Perphenazine (INN) and its salts | (521) | 320 |
| 513 | PETN | 505, 506 | 265 |
| 514 | Petrichloral (INN) | 504 | 266 |
| 515 | Phenacemide (INN) | 524 | 269 |
| 516 | Phenaglycodol (INN) | 161 | 95 |
| 517 | Phenetamine | 206 | 112 |
| 518 | Phenindone (INN) | 534 | 271 |
| 519 | Phenmetrazine (INN), its derivatives and salts | 448 | 232 |
| 520 | Phenobarbitone and its salts | (68) | 220 |
| 521 | Phenothiazine (INN) and its compounds | various | 320 |
| 522 | Phenprobamate (INN) | 536 | 71 |
| 523 | Phenprocoumon (INN) | 537 | 273 |
| 524 | N-Phenylacetylurea | 515 | 269 |
| 525 | 4-Phenylazophenylene-1,3-diamine citrate hydrochloride | 177 | 81 |
| 526 | Phenylbutazone (INN) | 123 | 67 |
| 527 | 4-Phenylbut-3-en-2-one | 89 | 356 |
| 528 | N-(2-Phenylbutyryl)urea | 314 | 272 |
| 529 | N-[2-(α-Phenyl—p-chlorobenzyl)-ethyl]morpholine | 242 | 270 |
| 530 | 1-Phenylcyclopentanecarboxylic acid diethylaminoethyl ester and its salts | 134 | 169 |
| 531 | 2-Phenylcyclopropylamine (trans-form) and its salts | 665, 666 | 324 |
| 532 | 1-Phenyl-2,3-dimethyl-4-isopropylpyrazol-5-one | 576 | 138 |
| 533 | o-Phenylenediamine and its salts | 220 | 363 |
| 534 | 2-Phenylindan-1,3-dione | 518 | 271 |
| 535 | α-Phenyl-2-piperidineacetic acid methyl ester and its salts | 445 | 175 |
| 536 | 1-Phenylpropan-1-ol carbamate | 522 | 71 |
| 537 | 3-(α-Phenylpropyl)-4-hydroxycoumarin | 523 | 273 |
| 538 | 1-Phenyl-2-(2-pyridylamino)ethanol | 320, 541 | 274 |
| 539 | 2-Phenylquinoline-4-carboxylic acid, its saltsand derivatives and salts of those derivatives | 179 | 8 |
| 540 | 6-Phenyl-2,4,7-triaminopteridine and its salts | 669 | 275 |
| 541 | Phenyramidol | 320, 538 | 274 |
| 542 | Phosphides, metal | 543 | 279 |
| 543 | Phosphorus | 542 | 279 |
| 544 | 4-Phosphoryloxy—N,N-dimethyl-tryptamine | 578 | 278 |
| 545 | 3-Phthalimidopiperidine-2,6-dione and its salts | 647 | 280 |
| 546 | Phthalylsulphathiazole (INN) and its salts | (622) | 307 |
| 547 | Physostigma venenosum Balf. | 129 | 281 |
| 548 | Physostigmine and its salts | 297 | 166 |
| 549 | Phytolacca Spp and their preparations | — | 374 |
| 550 | Picric acid | 375, 689 | 268 |
| 551 | Picrotoxin | 184 | 282 |
| 552 | Pilocarpine and its salts | — | 283 |
| 553 | Pilocarpus jaborandi Holmes and its galenical preparations | — | 311 |
| 554 | Pipazetate (INN) and its salts | 555 | 118 |
| 555 | 2-(2-Piperidinoethoxy)ethyl-10-thia-1,9-diazaanthracene-9-carboxylate and its salts | 554 | 118 |
| 556 | α-Piperidin-2-ylbenzyl acetate, laevorotatorythreo-form | 400 | 284 |
| 557 | β-(2-Piperidyl)propionaldehyde and its salts | 501 | 263 |
| 558 | 6-(Piperidinyl)-2,4-pyrimidinediamine-3-oxide (Minoxidil) and its salts and derivatives | 454 | 372 |
| 559 | Pipradrol (INN) and its salts | 284 | 285 |
| 560 | Piprocurarium iodide (INN) | 232 | 137 |
| 561 | Poldine metilsulfate (INN) (or methylsulphate) | 81 | 239 |
| 562 | Polyacetaldehyde | 417 | 223 |
| 563 | Potassium nitroferricyanide | 15, 564, 594–5 | 255 |
| 564 | Potassium nitroprusside | 15, 563, 594–5 | 255 |
| 565 | Probenecid (INN) | 288 | 161 |
| 566 | Procainamide (INN), its salts and derivatives | 30 | 25 |
| 567 | Prochlorperazine (INN) and its salts | (521) | 320 |
| 568 | Progestogens (except progesterone and ethisterone) | — | 194 |
| 569 | Promazine (INN) and its salts | (521) | 320 |
| 570 | Promethazine (INN) and its salts | (521) | 320 |
| 571 | Propane-1,2,3-triyl trinitrate | 339, 480 | 253 |
| 572 | Propatylnitrate (INN) | 104 | 206 |
| 573 | 1-Propyl-3-(4-chlorobenzene-sulphonyl)urea | 169 | 79 |
| 574 | 2-Propylpiperidine | 192 | 290 |
| 575 | 1-(2-Propynyl)cyclohexyl carbamate | 358 | 115 |
| 576 | Propyphenazone (INN) | 532 | 138 |
| 577 | Prunus laurocerasus L. | 145 | 291 |
| 578 | Psilocybine (INN) | 544 | 278 |
| 579 | Pyrethrum album L. and its galenical preparations | — | 345 |
| 580 | Pyrianisamine maleate | 426 | 346 |
| 581 | Pyribenzamine | 92, 692 | 347 |
| 582 | Pyrithione sodium (INNM) | — | 369 |
| 583 | Quinalbarbitone and its salts | (68) | 220 |
| 584 | Radioactive substances (except substances which are radioactive naturally or by reason of contamination from the environment, which have not been enriched for manufacturing purposes, and of which the concentration complies with Council Directive No. 76/579/Euratom[^f00019]) | — | 293 |
| 585 | Rauwolfia serpentina alkaloids and their salts | 586 | 15 |
| 586 | Reserpine (INN) and its salts | (585) | 15 |
| 587 | α-Santonin | 355 | 217 |
| 588 | Safrole (except natural content of essences in cases where the concentration of such safrole in the cosmetic product does not exceed– in the case of oral hygiene or dental products other than toothpaste intended specifically for children, 50 ppm; or in the case of products other than oral hygiene or dental products, 100 ppm.) | — | 360 |
| 589 | Schoenocaulon officinale Lind.(seeds and galenical preparations) | — | 332 |
| 590 | Scopolamine, its salts and derivatives | 377 | 295 |
| 591 | Secbutobarbitone and its salts | (68) | 220 |
| 592 | Selenium and its compounds except when permitted under the restrictions laid down in Part I of Schedule 2 | — | 297 |
| 593 | Sodium hexacyclonate (INN) | 370 | 114 |
| 594 | Sodium nitroferricyanide | 15, 563, 564, 595 | 255 |
| 595 | Sodium nitroprusside | 15, 563, 564,594 | 255 |
| 596 | Solanum nigrum L. and its galenical preparations | — | 298 |
| 597 | Spanish Fly | 130 | 69 |
| 598 | Sparteine (INN) and its salts | 405 | 299 |
| 599 | Spironolactone (INN) | 10 | 4 |
| 600 | Squill and its preparations | 696 | 330 |
| 601 | Stramonium and its preparations | 212 | 301 |
| 602 | Strophanthines and their aglucones and their respective derivatives | — | 302 |
| 603 | Strophanthus species and their galenical preparations | — | 303 |
| 604 | Strychnine and its salts | — | 304 |
| 605 | Strychnos species and their galenical preparations | 486 | 305 |
| 606 | Succinonitrile | — | 150 |
| 607 | Succinylsulphathiazole and its salts | (622) | 307 |
| 608 | Sulfinpyrazone (INN) | 283 | 155 |
| 609 | Sulphacetamide and its salts | (622) | 307 |
| 610 | Sulphadiazine and its salts | (622) | 307 |
| 611 | Sulphadimethoxine and its salts | (622) | 307 |
| 612 | Sulphadimidine and its salts | (622) | 307 |
| 613 | Sulphafurazole and its salts | (622) | 307 |
| 614 | Sulphaguanidine and its salts | (622) | 307 |
| 615 | Sulphamethizole and its salts | (622) | 307 |
| 616 | Sulphamethoxazole and its salts | (622) | 307 |
| 617 | Sulphamethoxydiazine and its salts | (622) | 307 |
| 618 | Sulphamethoxypyridazine and its salts | (622) | 307 |
| 619 | Sulphanilamide and its salts | (622) | 307 |
| 620 | Sulphapyridine and its salts | (622) | 307 |
| 621 | Sulphathiazole and its salts | (622) | 307 |
| 622 | Sulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the —NH₂ groups) and their salts | various | 307 |
| 623 | Sulthiame | 624, 643 | 308 |
| 624 | Sultiame (INN) | 623, 643 | 308 |
| 625 | Sympathomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and are referred to in resolution AP (69) 2 of the Council of Europe | 44 | 21 |
| 626 | Tefazoline (INN) and its salts | 642 | 237 |
| 627 | Tellurium and its compounds | — | 312 |
| 628 | TEPP (ISO) | 640 | 276 |
| 629 | 2-(4—tert-Butyl-2,6-dimethylbenzyl)-imidazoline and its salts | 708 | 313 |
| 630 | 4—tert-Butylphenol | — | 340 |
| 631 | 4—tert-butylpyrocatechol | — | 341 |
| 632 | Tetrabenazine (INN) and its salts | 494 | 139 |
| 633 | Tetrabromosalicylanilides | — | 350 |
| 634 | Tetracaine (INN) and its salts | 258 | 63 |
| 635 | 2,3,7,8-Tetrachlorodibenzo—p-dioxin | — | 367 |
| 636 | Tetrachloroethylene | 511 | 314 |
| 637 | Tetrachloromethane | 138 | 315 |
| 638 | Tetrachlorosalicylanilides | — | 348 |
| 639 | Tetraethylammonium bromide | 646 | 61 |
| 640 | Tetraethyl pyrophosphate | 628 | 276 |
| 641 | 5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-dihydric alcohol and its salts | 58 | 42 |
| 642 | 2-(5,6,7,8-Tetrahydro-1-methyl-2-naphthyl)-2-imidazoline and its salts | 626 | 237 |
| 643 | 4-(Tetrahydro-2H-1,2-thiazin-2-yl)-benzenesulphonamideS,S-dioxide | 623, 624 | 308 |
| 644 | N,2,3,3-Tetramethyl-2-norcamphanamine | 410 | 229 |
| 645 | Tetramethylthiuam disulphide | 289, 656 | 162 |
| 646 | Tetrylammonium bromide (INN) | 639 | 61 |
| 647 | Thalidomide (INN) and its salts | 545 | 280 |
| 648 | Thallium and its compounds | — | 317 |
| 649 | Thevetia neriifolia Juss., glycoside extract | — | 318 |
| 650 | Thiamazole (INN) | 444 | 233 |
| 651 | 2,2'-Thiobis(4,6-dichlorophenol) | 106 | 352 |
| 652 | Thiopentone and its salts | (68) | 220 |
| 653 | Thioridazine (INN) and its salts | (521) | 320 |
| 654 | Thiotepa (INN) | 670, 683 | 310 |
| 655 | Thiourea and its derivatives (except the one listed in Part I of Schedule 2) | — | 321 |
| 656 | Thiram (ISO) | 289, 645 | 162 |
| 657 | Thiuram disulphides | — | 354 |
| 658 | Thiuram monosulphides | — | 353 |
| 659 | Thyropropic acid (INN) and its salts | 369 | 9 |
| 660 | Tolboxane (INN) | 663 | 177 |
| 661 | Tolbutamide (INN) | 125 | 65 |
| 662 | Toluidines, their isomers, salts and halogenated and sulphonated derivatives | 40 | 32 |
| 663 | p-Tolylboric acid ester of 2-methyl-2-propylpropane-1,3-diol | 660 | 177 |
| 664 | 3—o-Tolyloxypropane-1,2-diol | 412 | 322 |
| 665 | trans-2-Phenylcyclopropylamine and its salts | 531, 666 | 324 |
| 666 | Tranylcypromine (INN) and its salts | 531, 665 | 324 |
| 667 | Tretamine (INN) | 682 | 328 |
| 668 | Tretinoin (INN) (retinoic acid and its salts) | — | 375 |
| 669 | Triamterene (INN) and its salts | 540 | 275 |
| 670 | Triaziridin-1-ylphosphine sulphide | 654, 683 | 310 |
| 671 | 2,2,2-Tribromoethanol | 672 | 326 |
| 672 | Tribromoethyl alcohol | 671 | 326 |
| 673 | 3,4,5-Tribromosalicylanilide (Tribromsalan) | — | 373 |
| 674 | Trichlormethine (INN) and its salts | 678 | 327 |
| 675 | Trichloroacetic acid | — | 10 |
| 676 | 1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane | 182, 213 | 123 |
| 677 | 2,2,2-Trichloroethane-1,1-diol | 146 | 77 |
| 678 | Tri(β-chloroethyl)amine and its salts | 674 | 327 |
| 679 | Trichloromethane | 156 | 366 |
| 680 | N-(Trichloromethylthio)-4-cyclohex-4-ene-1,2-dicarboximide (Captan) | 132 | 370 |
| 681 | Tricresyl phosphate | 694 | 277 |
| 682 | 2,4,6-Triethyleneimino-1,3,5-triazine | 667 | 328 |
| 683 | N,N,N-Triethylenethiophosphamide | 654, 670 | 310 |
| 684 | Trifluoperazine (INN) and its salts | (521) | 320 |
| 685 | Trifluperidol (INN) | 323 | 188 |
| 686 | 3,3',5-Triiodothyroacetic acid and its salts | 368 | 5 |
| 687 | 3,4,5-Trimethoxyphenethylamine and its salts | 415 | 222 |
| 688 | 2-2-6-Trimethyl-4-piperidyl benzoate and its salts | 74 | 51 |
| 689 | 2,4,6-Trinitrophenol | 375, 550 | 268 |
| 690 | Trioxysalan (INN) (except natural content ofessences) | 332, 333, 434 | 358 |
| 691 | Triparanol (INN) | 233 | 92 |
| 692 | Tripelennamine (INN) | 92, 581 | 347 |
| 693 | 1,2,3-Tris(2-triethylammonium-ethoxy)benzene triiodide | 336 | 329 |
| 694 | Tritolyl phosphate | 681 | 277 |
| 695 | Tuaminoheptane (INN), its isomers and salts | 31 | 27 |
| 696 | Urginea scilla Stern. and its galenical preparations | 600 | 330 |
| 697 | Vaccines, toxins and serums listed in the Annex to Council Directive No. 75/319/EEC[^f00020] | — | 323 |
| 698 | Valnoctamide (INN) | 313 | 184 |
| 699 | Veratrine, its salts and galenical preparations | — | 331 |
| 700 | Veratrum spp and their preparations | — | 333 |
| 701 | Vinyl chloride monomer | — | 334 |
| 702 | Vinylidene chloride | 7, 227 | 126 |
| 703 | Vitamins D₂ and D₃ | 174, 295 | 335 |
| 704 | Warfarin (ISO) and its salts | 2,372 | 203 |
| 705 | Xanthates | 16 | 336 |
| 706 | Xanthinol | 367 | 135 |
| 707 | Xylidines, their isomers, salts and halogenated and sulphonated derivatives | 41 | 33 |
| 708 | Xylometazoline (INN) and its salts | 629 | 313 |
| 709 | Yohimbine and its salts | — | 337 |
| 710 | Zoxazolamine (INN) | 29 | 24 |
SCHEDULE 2 — LIST OF SUBSTANCES WHICH COSMETIC PRODUCTS MUST NOT CONTAIN EXCEPT SUBJECT TO RESTRICTIONS
In this Schedule, the matters specified in columns 3, 4, 5 and 6 which apply to a particular substance are those set out to the right of its name as mentioned in column 2; and the matters specified in columns 4, 5 and 6 which apply in any particular case are those set out to the right of the matter specified in column 3 which applies in that case. The substance may not be used except for the purposes or contained other than in the types of product specified in column 3. The concentration of the substance in a product may not exceed the limit specified in column 4: where the names of two or more substances are mentioned in a single item as set out in column 2 and a product contains more than one of those substances, the limit specified in column 4 is the limit for all of those substances taken together; and where a product is intended to be mixed with another product in specified proportions before use, the level of concentration shall be calculated by reference to the mixture. Other requirements are specified in column 5. In column 4 of this Schedule, the percentage concentration is measured by reference to mass (m/m) unless a contrary intention appears.
PART I — substances listed in annex iii, part i of the directive as substances which cosmetic products must not contain except subject to the restrictions laid down
Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.
This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence.
legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.